Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cisplatin, Cancer research, Apoptosis, Biology, Ovarian cancer, and PTEN.
miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway
A Functional Variant at the miR-214 Binding Site in the Methylenetetrahydrofolatereductase Gene Alters Susceptibility to Gastric Cancer in a Chinese Han Population
Expression of Concern: miR‐145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6
Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway
Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells
Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis
miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells
Tetrandrine Induces Mitochondria-Mediated Apoptosis in Human Gastric Cancer BGC-823 Cells